ECOG-ACRIN E4512

A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

For more information about this clinical trial, click here.

Schema & Eligibility ECOG-ACRIN E4512

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Central Care Cancer Center, Bolivar, MO
Freeman Health System, Joplin, MO
Mercy Hospital, Joplin, MO
Phelps County Regional Medical Center, Rolla, MO
Mercy Clinic, Rolla, MO
Mercy Hospital, St. Louis, MO
St. Louis Cancer & Breast Institute, St. Louis, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Hospital, Oklahoma City, OK
Mosaic Life Care, St. Joseph, MO

Ask your physician about participating in this clinical trial or call CRO.